Cover Image

Importance of sample size determination for randomized controlled clinical trials for coronavirus disease 2019 antiviral therapies

Saved in:

Bibliographic Details
Main Author:	Getu Zhaori (Author)
Format:	Book
Published:	Wiley, 2024-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Better design leads to better results - Importance of virological outcome design in clinical trials for antiviral treatment of coronavirus disease 2019
by: Getu Zhaori, et al.
Published: (2023)

Further standardization and safety issues for antiviral therapy during pregnancy
by: Getu Zhaori
Published: (2020)

Pharmacists as important prescribers of coronavirus disease 2019 (COVID-19) antivirals
by: Monica V. Mahoney, et al.
Published: (2022)

Smoke evacuation, is it important for prevention of COVID‐19?
by: Getu Zhaori
Published: (2020)

Nirsevimab brings breakthrough in the prevention of respiratory syncytial virus infection in infants - Importance of design
by: Getu Zhaori
Published: (2023)

Concepts in sample size determination
by: Umadevi K Rao
Published: (2012)

A new column in this journal - Forum on Clinical Investigation
by: Getu Zhaori
Published: (2023)

Sample Size Estimation in Clinical Trials
by: Divyangkumar Patel
Published: (2024)

Reporting Sample Size Calculation in Randomized Clinical Trials Published in 4 Orthodontic Journals
by: Marialicia Calderon-Augusto, et al.
Published: (2021)

Old problem may have new solution
by: Getu Zhaori
Published: (2018)

Professor Robert Freedman and his contributions to psychiatric research
by: Getu Zhaori
Published: (2020)

Severe acute hepatitis of unknown causes in children - Current findings, questions, opinions, and recommendations, a mini‐review
by: Getu Zhaori
Published: (2022)

Sample Size Determination in Medical Education Research
by: Sara Shafian, et al.
Published: (2022)

On Validty of Assumptions while Determining Sample Size
Published: (2004)

Simplified Sample Size Formulas for Detecting a Medically Important Effect
by: Abhaya Indrayan, et al.
Published: (2024)

Biostatistics series module 5: Determining sample size
by: Avijit Hazra, et al.
Published: (2016)

Effectiveness of Fortified Garlic Extract Oral Capsules as Adjuvant Therapy in Hospitalized Patients with Coronavirus Disease 2019: A Triple-Blind Randomized Controlled Clinical Trial
by: Mohammad Reza Taghavi, MD, et al.
Published: (2023)

Collaboration in orthodontic clinical trials: prevalence and association with sample size and funding
by: D. Al-Moghrabi, et al.
Published: (2018)

Collaborative studies of U.S.-China neurologists on acute motor axonal neuropathy
by: Junlan Lv, et al.
Published: (2022)

Antiviral Efficacy and Safety of Molnupiravir Against Omicron Variant Infection: A Randomized Controlled Clinical Trial
by: Rongrong Zou, et al.
Published: (2022)

Antiviral Treatment in COVID-19 Outpatients: A Systematic Review of Randomized Controlled Trials
by: David Setyo Budi, et al.
Published: (2022)

Doxycycline in the Coronavirus Disease 2019 Therapy
by: Dorobisz K, et al.
Published: (2021)

Clinical and diagnostic importance of dyslipidemia in children and adolescents during the coronavirus disease 2019 pandemic
by: Eun Young Kim
Published: (2022)

Sample sizes in dosage investigational clinical trials: a systematic evaluation
by: Huang JH, et al.
Published: (2015)

Reporting of sample size parameters for randomized controlled trials published in high impact factor endodontic journals in the last decade: A bibliometric analysis
by: Fahad Umer, et al.
Published: (2021)

Importance of the Size of Adenomatous Polyps in Determining Appropriate Colonoscopic Surveillance Intervals
by: Hoon Sup Koo, et al.
Published: (2018)

Sample size estimation
by: N Gopi Chander
Published: (2017)

Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection
by: Seyed Abdulmajid Ayatollahi, et al.
Published: (2021)

Importance of timely management of patients in reducing fatality rate of coronavirus disease 2019
by: Yuzhu Peng, et al.
Published: (2020)

Do patient characteristics matter when calculating sample size for eczema clinical trials?
by: L. Howells, et al.
Published: (2021)

The methodology of calculation of sample size in "non-inferiority" comparative controlled clinical trials: a comparison of two proportions in parallel group
by: A. A. Lyashenko, et al.
Published: (2018)

Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review
by: Shahamah Jomah, et al.
Published: (2020)

Error in sample size formula
by: Desmond Dedalus Campbell
Published: (2014)

Sample size considerations in research
by: Shyam Sivasamy
Published: (2023)

Large Sample Size Fallacy in Trials About Antipsychotics for Neuropsychiatric Symptoms in Dementia
by: Tessa A. Hulshof, et al.
Published: (2020)

Impact of the Coronavirus Disease 2019 pandemic on an ongoing pragmatic pediatric clinical trial
by: Abrar F Hudairi, et al.
Published: (2021)

Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology
by: Veronica Agostinelli, et al.
Published: (2023)

Huashi baidu granule in the treatment of pediatric patients with mild coronavirus disease 2019: A single-center, open-label, parallel-group randomized controlled clinical trial
by: Jiande Chen, et al.
Published: (2023)

Using value of information methods to determine the optimal sample size for effectiveness trials of alcohol interventions for HIV-infected patients in East Africa
by: Lingfeng Li, et al.
Published: (2018)

Adenine: an important drug scaffold for the design of antiviral agents
by: Changyuan Wang, et al.
Published: (2015)